 | |||||
| lose weight | |||||
| NEWS | |||||
| Roche's 22% Weight Loss Benefit Seals GLP-1's Phase III Plans, Boosts Zealand Combo Roche said the Phase II results help build the case for advancing CT-388 into late-stage testing, which is set to get underway this quarter.
| |||||
| See more results | Edit this alert | |||||
| You have received this email because you have subscribed to Google Alerts. |
 Receive this alert as RSS feed |
| Send Feedback |
